Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular Autism
Published in: Molecular Autism 1/2011

Open Access 01-12-2011 | Research

Functionality of promoter microsatellites of arginine vasopressin receptor 1A (AVPR1A): implications for autism

Authors: Katherine E Tansey, Matthew J Hill, Lynne E Cochrane, Michael Gill, Richard JL Anney, Louise Gallagher

Published in: Molecular Autism | Issue 1/2011

Login to get access

Abstract

Background

Arginine vasopressin (AVP) has been hypothesized to play a role in aetiology of autism based on a demonstrated involvement in the regulation of social behaviours. The arginine vasopressin receptor 1A gene (AVPR1A) is widely expressed in the brain and is considered to be a key receptor for regulation of social behaviour. Moreover, genetic variation at AVPR1A has been reported to be associated with autism. Evidence from non-human mammals implicates variation in the 5'-flanking region of AVPR1A in variable gene expression and social behaviour.

Methods

We examined four tagging single nucleotide polymorphisms (SNPs) (rs3803107, rs1042615, rs3741865, rs11174815) and three microsatellites (RS3, RS1 and AVR) at the AVPR1A gene for association in an autism cohort from Ireland. Two 5'-flanking region polymorphisms in the human AVPR1A, RS3 and RS1, were also tested for their effect on relative promoter activity.

Results

The short alleles of RS1 and the SNP rs11174815 show weak association with autism in the Irish population (P = 0.036 and P = 0.008, respectively). Both RS1 and RS3 showed differences in relative promoter activity by length. Shorter repeat alleles of RS1 and RS3 decreased relative promoter activity in the human neuroblastoma cell line SH-SY5Y.

Conclusions

These aligning results can be interpreted as a functional route for this association, namely that shorter alleles of RS1 lead to decreased AVPR1A transcription, which may proffer increased susceptibility to the autism phenotype.
Appendix
Available only for authorised users
Literature
1.
Goodson JL, Bass AH: Social behavior functions and related anatomical characteristics of vasotocin/vasopressin systems in vertebrates. Brain Res Brain Res Rev. 2001, 35: 246-265. 10.1016/S0165-0173(01)00043-1.CrossRefPubMed
2.
Bales KL, Plotsky PM, Young LJ, Lim MM, Grotte N, Ferrer E, Carter CS: Neonatal oxytocin manipulations have long-lasting, sexually dimorphic effects on vasopressin receptors. Neuroscience. 2007, 144: 38-45. 10.1016/j.neuroscience.2006.09.009.PubMedCentralCrossRefPubMed
3.
Ferris WF, Naran NH, Crowther NJ, Rheeder P, van der Merwe L, Chetty N: The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res. 2005, 37: 695-701. 10.1055/s-2005-870580.CrossRefPubMed
4.
Chakrabarti S, Fombonne E: Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry. 2005, 162: 1133-1141. 10.1176/appi.ajp.162.6.1133.CrossRefPubMed
5.
Boso M, Emanuele E, Politi P, Pace A, Arra M, Ucelli di Nemi S, Barale F: Reduced plasma apelin levels in patients with autistic spectrum disorder. Arch Med Res. 2007, 38: 70-74. 10.1016/j.arcmed.2006.08.003.CrossRefPubMed
6.
Bielsky IF, Hu SB, Young LJ: Sexual dimorphism in the vasopressin system: lack of an altered behavioral phenotype in female V1a receptor knockout mice. Behav Brain Res. 2005, 164: 132-136. 10.1016/j.bbr.2005.06.005.CrossRefPubMed
7.
Bielsky IF, Hu SB, Szegda KL, Westphal H, Young LJ: Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology. 2004, 29: 483-493. 10.1038/sj.npp.1300360.CrossRefPubMed
8.
Lim MM, Bielsky IF, Young LJ: Neuropeptides and the social brain: potential rodent models of autism. Int J Dev Neurosci. 2005, 23: 235-243. 10.1016/j.ijdevneu.2004.05.006.CrossRefPubMed
9.
Young LJ, Toloczko D, Insel TR: Localization of vasopressin (V1a) receptor binding and mRNA in the rhesus monkey brain. J Neuroendocrinol. 1999, 11: 291-297. 10.1046/j.1365-2826.1999.00332.x.CrossRefPubMed
10.
Insel TR, Wang ZX, Ferris CF: Patterns of brain vasopressin receptor distribution associated with social organization in microtine rodents. J Neurosci. 1994, 14: 5381-5392.PubMed
11.
Young LJ, Winslow JT, Nilsen R, Insel TR: Species differences in V1a receptor gene expression in monogamous and nonmonogamous voles: behavioral consequences. Behav Neurosci. 1997, 111: 599-605. 10.1037/0735-7044.111.3.599.CrossRefPubMed
12.
Hammock EA, Young LJ: Variation in the vasopressin V1a receptor promoter and expression: implications for inter- and intraspecific variation in social behaviour. Eur J Neurosci. 2002, 16: 399-402. 10.1046/j.1460-9568.2002.02083.x.CrossRefPubMed
13.
Hammock EA, Lim MM, Nair HP, Young LJ: Association of vasopressin 1a receptor levels with a regulatory microsatellite and behavior. Genes Brain Behav. 2005, 4: 289-301. 10.1111/j.1601-183X.2005.00119.x.CrossRefPubMed
14.
Hammock EA, Young LJ: Microsatellite instability generates diversity in brain and sociobehavioral traits. Science. 2005, 308: 1630-1634. 10.1126/science.1111427.CrossRefPubMed
15.
Thibonnier M, Graves MK, Wagner MS, Chatelain N, Soubrier F, Corvol P, Willard HF, Jeunemaitre X: Study of V(1)-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension. J Mol Cell Cardiol. 2000, 32: 557-564. 10.1006/jmcc.2000.1108.CrossRefPubMed
16.
Kim SJ, Young LJ, Gonen D, Veenstra-VanderWeele J, Courchesne R, Courchesne E, Lord C, Leventhal BL, Cook EH, Insel TR: Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Mol Psychiatry. 2002, 7: 503-507. 10.1038/sj.mp.4001125.CrossRefPubMed
17.
Wassink TH, Piven J, Vieland VJ, Pietila J, Goedken RJ, Folstein SE, Sheffield VC: Examination of AVPR1a as an autism susceptibility gene. Mol Psychiatry. 2004, 9: 968-972. 10.1038/sj.mp.4001503.CrossRefPubMed
18.
Yirmiya N, Rosenberg C, Levi S, Salomon S, Shulman C, Nemanov L, Dina C, Ebstein RP: Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills. Mol Psychiatry. 2006, 11: 488-494. 10.1038/sj.mp.4001812.CrossRefPubMed
19.
Yang SY, Cho SC, Yoo HJ, Cho IH, Park M, Yoe J, Kim SA: Family-based association study of microsatellites in the 5' flanking region of AVPR1A with autism spectrum disorder in the Korean population. Psychiatry Res. 2010, 178: 199-201. 10.1016/j.psychres.2009.11.007.CrossRefPubMed
20.
Knafo A, Israel S, Darvasi A, Bachner-Melman R, Uzefovsky F, Cohen L, Feldman E, Lerer E, Laiba E, Raz Y, Nemanov L, Gritsenko I, Dina C, Agam G, Dean B, Bornstein G, Ebstein RP: Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA. Genes Brain Behav. 2008, 7: 266-275. 10.1111/j.1601-183X.2007.00341.x.CrossRefPubMed
21.
Meyer-Lindenberg A, Kolachana B, Gold B, Olsh A, Nicodemus KK, Mattay V, Dean M, Weinberger DR: Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry. 2009, 14: 968-975. 10.1038/mp.2008.54.PubMedCentralCrossRefPubMed
22.
Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Almeida J, Bacchelli E, Bader GD, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bölte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Bryson SE, Carson AR, Casallo G, Casey J, Chung BH, Cochrane L, Corsello C: Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 466: 368-372. 10.1038/nature09146.
23.
Anney R, Klei L, Pinto D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Sykes N, Pagnamenta AT, Almeida J, Bacchelli E, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bölte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Carson AR, Casallo G, Casey J, Chu SH, Cochrane L, Corsello C, Crawford EL, Crossett A: A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet. 19: 4072-4082. 10.1093/hmg/ddq307.
24.
Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009, 460: 748-752.PubMed
25.
Lord C, Rutter M, Le Couteur A: Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994, 24: 659-685. 10.1007/BF02172145.CrossRefPubMed
26.
Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, DiLavore PC, Pickles A, Rutter M: The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord. 2000, 30: 205-223. 10.1023/A:1005592401947.CrossRefPubMed
27.
Sparrow SS, Cicchetti DV: Diagnostic uses of the Vineland Adaptive Behavior Scales. J Pediatr Psychol. 1985, 10: 215-225. 10.1093/jpepsy/10.2.215.CrossRefPubMed
28.
Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093/bioinformatics/bth457.CrossRefPubMed
29.
Dudbridge F: Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 2008, 66: 87-98. 10.1159/000119108.PubMedCentralCrossRefPubMed
30.
Galimberti D, Scarpini E, Venturelli E, Strobel A, Herterich S, Fenoglio C, Guidi I, Scalabrini D, Cortini F, Bresolin N, Lesch KP, Reif A: Association of a NOS1 promoter repeat with Alzheimer's disease. Neurobiol Aging. 2008, 29: 1359-1365. 10.1016/j.neurobiolaging.2007.03.003.CrossRefPubMed
31.
Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Topner T, Fritzen S, Walter U, Schmitt A, Fallgatter AJ, Lesch KP: A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry. 2006, 11: 286-300. 10.1038/sj.mp.4001779.CrossRefPubMed
32.
Reif A, Jacob CP, Rujescu D, Herterich S, Lang S, Gutknecht L, Baehne CG, Strobel A, Freitag CM, Giegling I, Romanos M, Hartmann A, Rösler M, Renner TJ, Fallgatter AJ, Retz W, Ehlis AC, Lesch KP: Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry. 2009, 66: 41-50. 10.1001/archgenpsychiatry.2008.510.CrossRefPubMed
33.
Reif A, Kiive E, Kurrikoff T, Paaver M, Herterich S, Konstabel K, Tulviste T, Lesch KP, Harro J: A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity. Psychopharmacology (Berl). 2010
34.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007, 81: 559-575. 10.1086/519795.PubMedCentralCrossRefPubMed
35.
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. Science. 2002, 296: 2225-2229. 10.1126/science.1069424.CrossRefPubMed
36.
Meyer-Lindenberg A, Kolachana B, Gold B, Olsh A, Nicodemus KK, Mattay V, Dean M, Weinberger DR: Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry. 2009, 14: 968-75. 10.1038/mp.2008.54.PubMedCentralCrossRefPubMed
37.
Stein MB, Goldin PR, Sareen J, Zorrilla LT, Brown GG: Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry. 2002, 59: 1027-1034. 10.1001/archpsyc.59.11.1027.CrossRefPubMed
38.
Israel S, Lerer E, Shalev I, Uzefovsky F, Reibold M, Bachner-Melman R, Granot R, Bornstein G, Knafo A, Yirmiya N, Ebstein RP: Molecular genetic studies of the arginine vasopressin 1a receptor (AVPR1a) and the oxytocin receptor (OXTR) in human behaviour: from autism to altruism with some notes in between. Prog Brain Res. 2008, 170: 435-449. full_text.CrossRefPubMed
39.
Hong KW, Matsukawa R, Hirata Y, Hayasaka I, Murayama Y, Ito S, Inoue-Murayama M: Allele distribution and effect on reporter gene expression of vasopressin receptor gene (AVPR1a)-linked VNTR in primates. J Neural Transm. 2009, 116: 535-538. 10.1007/s00702-009-0219-8.CrossRefPubMed
40.
Cowles CR, Hirschhorn JN, Altshuler D, Lander ES: Detection of regulatory variation in mouse genes. Nat Genet. 2002, 32: 432-437. 10.1038/ng992.CrossRefPubMed
41.
Koch O, Kwiatkowski DP, Udalova IA: Context-specific functional effects of IFNGR1 promoter polymorphism. Hum Mol Genet. 2006, 15: 1475-1481. 10.1093/hmg/ddl071.CrossRefPubMed
42.
Sun C, Southard C, Witonsky DB, Olopade OI, Di Rienzo A: Allelic imbalance (AI) identifies novel tissue-specific cis-regulatory variation for human UGT2B15. Hum Mutat. 31: 99-107. 10.1002/humu.21145.
43.
Wilkins JM, Southam L, Price AJ, Mustafa Z, Carr A, Loughlin J: Extreme context specificity in differential allelic expression. Hum Mol Genet. 2007, 16: 537-546. 10.1093/hmg/ddl488.CrossRefPubMed
44.
Zhang K, Li JB, Gao Y, Egli D, Xie B, Deng J, Li Z, Lee JH, Aach J, Leproust EM, Eggan K, Church GM: Digital RNA allelotyping reveals tissue-specific and allele-specific gene expression in human. Nat Methods. 2009, 6: 613-618. 10.1038/nmeth.1357.PubMedCentralCrossRefPubMed
45.
Levin R, Heresco-Levy U, Bachner-Melman R, Israel S, Shalev I, Ebstein RP: Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition. Psychoneuroendocrinology. 2009, 34: 901-908. 10.1016/j.psyneuen.2008.12.014.CrossRefPubMed
Metadata
Title
Functionality of promoter microsatellites of arginine vasopressin receptor 1A (AVPR1A): implications for autism
Authors
Katherine E Tansey
Matthew J Hill
Lynne E Cochrane
Michael Gill
Richard JL Anney
Louise Gallagher
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Molecular Autism / Issue 1/2011
Electronic ISSN: 2040-2392
DOI
https://doi.org/10.1186/2040-2392-2-3

Other articles of this Issue 1/2011

Molecular Autism 1/2011 Go to the issue

Research

Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study

Research

An X chromosome-wide association study in autism families identifies TBL1X as a novel autism spectrum disorder candidate gene in males

Research

Gene expression analysis in lymphoblasts derived from patients with autism spectrum disorder

Research

Increased copy number for methylated maternal 15q duplications leads to changes in gene and protein expression in human cortical samples

Research

A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism

Short report

Investigation of the serum levels of anterior pituitary hormones in male children with autism